DCVAX Trademark

Trademark Overview

On Wednesday, April 19, 2000, a trademark application was filed for DCVAX with the United States Patent and Trademark Office. The USPTO has given the DCVAX trademark a serial number of 76029211. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, April 5, 2023. This trademark is owned by Northwest Biotherapeutics, Inc.. The DCVAX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines
dcvax

General Information

Serial Number76029211
Word MarkDCVAX
Filing DateWednesday, April 19, 2000
Status800 - REGISTERED AND RENEWED
Status DateWednesday, April 5, 2023
Registration Number2636385
Registration DateTuesday, October 15, 2002
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 10, 2001

Trademark Statements

Goods and ServicesVaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 30, 2000
Primary Code005
First Use Anywhere DateWednesday, March 6, 2002
First Use In Commerce DateWednesday, March 6, 2002

Trademark Owner History

Party NameNorthwest Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBETHESDA, MD 20814
Party NameNorthwest Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBothell, WA 98021
Party NameNorthwest Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98134

Trademark Events

Event DateEvent Description
Monday, June 24, 2002USE AMENDMENT FILED
Wednesday, September 20, 2000ASSIGNED TO EXAMINER
Thursday, September 28, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 28, 2001NOTICE OF PUBLICATION
Tuesday, April 10, 2001PUBLISHED FOR OPPOSITION
Monday, May 7, 2001EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, September 10, 2001OPPOSITION INSTITUTED NO. 999999
Tuesday, October 30, 2001OPPOSITION DISMISSED NO. 999999
Tuesday, October 30, 2001OPPOSITION TERMINATED NO. 999999
Tuesday, December 25, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 8, 2012TEAS SECTION 8 & 9 RECEIVED
Thursday, June 27, 2002PAPER RECEIVED
Tuesday, July 16, 2002STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 18, 2002ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 15, 2002REGISTERED-PRINCIPAL REGISTER
Wednesday, December 26, 2007CASE FILE IN TICRS
Monday, April 20, 2009PAPER RECEIVED
Monday, April 20, 2009REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Wednesday, April 29, 2009ASSIGNED TO PARALEGAL
Monday, August 10, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 9, 2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, October 9, 2012REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, October 9, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, April 29, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 15, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, September 26, 2022TEAS SECTION 8 & 9 RECEIVED
Wednesday, April 5, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, April 5, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 5, 2023REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Wednesday, April 5, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

dcvax vaccines